The BETRECEP brand, founded in 2012 (United States), from 1125 sister brands and 17477 competing brands. BETRECEP is owned by Pfizer Inc, listed on the stock exchange of New York BETRECEP is part of the Drug Manufacturers activity sector.

BETRECEP is a brand of Pfizer Inc (PFE) Share price

Share price and profitability of the share Pfizer Inc (BETRECEP)

Buy Pfizer Inc share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 27.78

Portfolio valuation
Pfizer Inc (BETRECEP) over 5 years* USD 19.11

Stock market history Pfizer Inc (BETRECEP)